 |
 |

Dopamine Excretion and Vulnerability to Drug-Induced ParkinsonismSchizophrenic Patients
Thomas J. Crowley, MD;
Margaret M. Hoehn, MD;
Charles O. Rutledge, PhD;
Mary Ann Stallings, RN, MS;
Robert K. Heaton, PhD;
Seymour Sundell, MD;
Donald Stilson, PhD
Arch Gen Psychiatry. 1978;35(1):97-104.
Abstract
Before and during a standardized course of trifluoperazine therapy, 18 schizophrenic patients underwent repeated examinations for extrapyramidal motor signs, clinical psychopathology, and urinary excretion of free and conjugated forms of dopamine and its metabolites. Patients excreting more free dopamine and metabolites, or showing less complete conjugation, before drug treatment, were much less likely than others to develop parkinsonian akinesia and rigidity during drug treatment. Neither catatonic rigidity nor akinesia before treatment was predictive of a parkinsonian response to trifluoperazine, but pretreatment tremor may have been. The severity of schizophrenic psychopathology was unrelated to dopamine excretion. This study of schizophrenic patients, and our previous research in Parkinson's disease, suggest that urinary dopamine excretion may reflect dopaminergic function of the extrapyramidal motor system in both conditions.
Author Affiliations
From the Departments of Psychiatry (Drs Crowley, Heaton, Sundell, and Stilson and Ms Stallings), Neurology (Dr Hoehn), and Pharmacology (Dr Rutledge), University of Colorado Medical Center, Denver. Dr Rutledge is now with the Department of Pharmacology and Toxicology, School of Pharmacy, University of Kansas, Lawrence. Dr Sundell is now with the Denver Manager of Safety and Denver General Hospital.
Footnotes
Accepted for publication June 20, 1977.
Read in part before the annual meeting of the American Psychiatric Association, Toronto, May 4, 1977.
Reprint requests to Department of Psychiatry, University of Colorado Medical Center, 4200 E Ninth Ave, Denver, CO 80220 (Dr Crowley).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Motility, Parkinsonism, and Prolactin With Thiothixene and Thioridazine
Crowley and Hydinger-Macdonald
Arch Gen Psychiatry 1981;38:668-675.
ABSTRACT
|